Trial
NCT02206932
A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Francisco
Collaborators
Janssen Scientific Affairs, LLC
Condition
Hepatitis C, Chronic
Intervention
Sofosbuvir + Simeprevir
Why stopped
never opened
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-13